Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

myositis ossificans News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A case report details a rare overlap syndrome of pembrolizumab-induced myocarditis, myositis, and myasthenia gravis in a patient with endometrial carcinoma. The report highlights concurrent hepatitis and thyroiditis, emphasizing the complexity of immune-related adverse events.

A recent study highlights the complexities of diagnosing and treating calcinosis cutis and delayed-onset myositis in a patient with suspected localized scleroderma. This case underscores the need for careful evaluation in rare disease presentations.

Not rare diseases news,news about your rare disease.

Earlier

A case report details a rare overlap syndrome of pembrolizumab-induced myocarditis, myositis, and myasthenia gravis in a patient with endometrial carcinoma. The report highlights concurrent hepatitis and thyroiditis, emphasizing the complexity of immune-related adverse events.

A recent study highlights the complexities of diagnosing and treating calcinosis cutis and delayed-onset myositis in a patient with suspected localized scleroderma. This case underscores the need for careful evaluation in rare disease presentations.

Not rare diseases news,
news about your rare disease.